secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zura Bio Ltd (ZURA)
CIK:        0001855644
Form:       8-K
Filed at:   2025-09-30T23:59:59+00:00
Accession:  0001104659-25-095024
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zura Bio adopts Executive Severance Benefit Plan for CEO and named executives
-----------------------------------------------------------------------------

- CEO: 12 months base salary on regular termination; 18 months + 150% target bonus on change-in-control termination.
- Other named executives: 9 months base salary (regular) or 12 months + 100% target bonus (change-in-control).
- Plan effective September 24, 2025; requires signed release agreement for eligibility.
- Supersedes any prior severance agreements or arrangements for covered executives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855644/000110465925095024/0001104659-25-095024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855644/000110465925095024/tm2527486d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-095024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer